Skip to main content

Table 2 Multivariable Cox proportional hazards model

From: Candidate methylation sites associated with endocrine therapy resistance in ER+/HER2- breast cancer

 

HR

95% CI

P-value

Stage (per stage increment)

2.15

1.61–2.89

3.05E-07

Age (per 1-yr increment)

1.04

1.02–1.05

2.48E-06

AI treatment (vs. no AI treatment)

0.61

0.40–0.94

0.026

  1. Multivariable Cox proportional hazards model for clinical variables (ER+/HER2- cohort). HR hazard ratio, CI confidence interval, AI aromatase inhibitor
Back to article page